{
  "_id": "68028e9b3ccffd1c7912c8ce",
  "ipo_id": "2023_concord_biotech_limited_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": true,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": true
    },
    "scrapedAt": "2025-04-18T17:31:37.446Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/concord-biotech-ipo/1472/"
  },
  "about": {
    "details": "<p>Incorporated in 1984, Concord Biotech Limited is an India-based R&amp;D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.</p>\n<p>Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.</p>\n<p>The company manufactures Active Pharmaceutical Ingredients (API) through fermentation &amp; semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.</p>\n<p>Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals &amp; others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.</p>"
  },
  "additionalTables": [
    {
      "heading": "Company Financials",
      "sanitizedHeading": "financials",
      "headers": [
        "Period Ended",
        "31 Mar 2021",
        "31 Mar 2022",
        "31 Mar 2023"
      ],
      "rows": [
        [
          "Assets",
          "1182.55",
          "1312.80",
          "1513.98"
        ],
        [
          "Revenue",
          "630.75",
          "736.35",
          "888.48"
        ],
        [
          "Profit After Tax",
          "234.89",
          "174.93",
          "240.08"
        ],
        [
          "Net Worth",
          "999.37",
          "1103.22",
          "1290.00"
        ],
        [
          "Reserves and Surplus",
          null,
          null,
          null
        ],
        [
          "Total Borrowing",
          "86.35",
          "60.59",
          "31.24"
        ]
      ]
    },
    {
      "heading": "Concord Biotech Limited Stock Quote & Charts",
      "sanitizedHeading": "concord_biotech_stock_quote_charts",
      "headers": [
        "KPI",
        "Values"
      ],
      "rows": [
        [
          "ROE",
          "20.06%"
        ],
        [
          "ROCE",
          "24.27%"
        ],
        [
          "RoNW",
          "20%"
        ]
      ]
    },
    {
      "heading": "Concord Biotech Limited Stock Quote & Charts",
      "sanitizedHeading": "concord_biotech_stock_quote_charts",
      "headers": [
        null,
        "Pre IPO",
        "Post IPO"
      ],
      "rows": [
        [
          "EPS (Rs)",
          "20.79",
          null
        ],
        [
          "P/E (x)",
          "32.29",
          null
        ]
      ]
    }
  ],
  "anchorInvestors": {
    "summary": "Concord Biotech IPO raises Rs 464.95 crore from anchor investors. Concord Biotech IPO Anchor bid date is August 3 2023. Concord Biotech IPO Anchor Investors list",
    "list_link": {
      "text": "Concord Biotech IPO Anchor Investors list",
      "url": "https://www.chittorgarh.net/reports/ipo_notes/concord-biotech-anchor-intimation-letter.pdf"
    },
    "details": {
      "ipo_date": "November 9 2023",
      "shares_offered": "6274695",
      "anchor_portion_size": "464.95"
    }
  },
  "basicDetails": {
    "ipoDate": "August 4, 2023 to August 8, 2023",
    "ipoListingDate": "Fri, Aug 18, 2023",
    "faceValue": "₹1 per share",
    "issuePrice": "₹741.00",
    "lotSize": "20 Shares",
    "issueSize": "2,09,25,652 shares (aggregating up to ₹1,551.00 Cr)",
    "offerForSale": "2,09,25,652 shares of ₹1 (aggregating up to ₹1,551.00 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "BSE, NSE",
    "ipoOpenDate": "Fri, Aug 4, 2023",
    "ipoCloseDate": "Tue, Aug 8, 2023",
    "initiationOfRefunds": "Mon, Aug 14, 2023",
    "creditOfSharesToDemat": "Thu, Aug 17, 2023",
    "shareHoldingPreIssue": "44.08%",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "44.08%"
      }
    ],
    "shareHoldingPostIssue": "10,46,16,204 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "10,46,16,204 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "44.08%"
      }
    ]
  },
  "closing_date": "2023-08-07T18:30:00.000Z",
  "contactDetails": {
    "phone": "079-6813 8700",
    "email": "complianceofficer@concordbiotech.com",
    "full_address": "Concord Biotech Limited, 1482-86, Trasad Road Dholka, Ahmedabad – 382225",
    "website": "http://www.concordbiotech.com/"
  },
  "createdAt": "2025-04-18T17:40:43.650Z",
  "faqs": [
    {
      "question": "What is the Concord Biotech IPO?",
      "answer": "<div itemprop=\"text\"><p>Concord Biotech IPO<!-- --> is a <b>main-board<!-- --> <!-- -->IPO<!-- --> of <!-- -->20925652<!-- --> equity shares</b> of the face value of ₹<!-- -->1<!-- --> aggregating up to ₹<!-- -->1,551.00<!-- --> Crores. The issue is priced at <span>₹741 per share</span>. The minimum order quantity is <!-- -->20<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->August 4, 2023</b>, and <b>closes on <!-- -->August 8, 2023</b>.</p><p>Link Intime India Private Ltd<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->BSE, NSE<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Concord Biotech IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Concord Biotech IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Concord Biotech IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Concord Biotech IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Concord Biotech IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Concord Biotech IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Concord Biotech IPO opens on August 4, 2023 and closes on August 8, 2023.</p></div>"
    },
    {
      "question": "What is the lot size of Concord Biotech IPO?",
      "answer": "<div itemprop=\"text\"><p>Concord Biotech IPO<!-- --> <b>lot size is <!-- -->20</b>, and the <b>minimum amount required is <span>₹14,820</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Concord Biotech IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Concord Biotech IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Concord Biotech IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Concord Biotech IPO<!-- --> will be done on <!-- -->Friday, August 11, 2023<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Thursday, August 17, 2023<!-- -->. Check the <a href=\"/ipo_allotment_status/concord-biotech-ipo/1472/\" title=\"Concord Biotech IPO Allotment Status\">Concord Biotech IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Concord Biotech IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Concord Biotech IPO<!-- --> listing date is on <b>Friday, August 18, 2023</b>.</p></div>"
    }
  ],
  "ipoName": "Concord Biotech",
  "issue_price": "₹741.00",
  "issue_price_numeric": 741,
  "issue_size": "2,09,25,652 shares (aggregating up to ₹1,551.00 Cr)",
  "issue_size_numeric": 2,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "Kotak Mahindra Capital Company Limited",
      "url": "/report/ipo-lead-manager-review/112/12/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/12/"
    },
    {
      "name": "Citigroup Global Markets India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/23/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/23/"
    },
    {
      "name": "Jefferies India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/112/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/112/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "bse": "741.00",
        "nse": "741.00"
      },
      "open": {
        "bse": "900.05",
        "nse": "900.05"
      },
      "low": {
        "bse": "900.00",
        "nse": "900.05"
      },
      "high": {
        "bse": "987.05",
        "nse": "987.70"
      },
      "last_trade": {
        "bse": "941.85",
        "nse": "942.80"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      },
      {
        "text": "Pre-Open Session - BSE",
        "url": "https://www.bseindia.com/eqstreamer/StockTickerSplPreOpen.html"
      }
    ],
    "ipo_date": "August 18 2023",
    "bse_script_code": "543960",
    "nse_symbol": "CONCORDBIO",
    "isin": "INE338H01029",
    "final_issue_price": "741 per share"
  },
  "listing_date": "2023-08-17T18:30:00.000Z",
  "listing_gains": "27.11%",
  "listing_gains_numeric": 27.11,
  "logo": "https://www.chittorgarh.net/images/ipo/concord-biotech-logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/concord-biotech-logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 20 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "20",
        "amount": "14820"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "13",
        "shares": "260",
        "amount": "192660"
      },
      "shni_min": {
        "application": "S-HNI (Min)",
        "lots": "14",
        "shares": "280",
        "amount": "207480"
      },
      "shni_max": {
        "application": "S-HNI (Max)",
        "lots": "67",
        "shares": "1340",
        "amount": "992940"
      },
      "bhni_min": {
        "application": "B-HNI (Min)",
        "lots": "68",
        "shares": "1360",
        "amount": "1007760"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/concord-biotech-ipo/1472/"
    }
  },
  "lot_size": 20,
  "opening_date": "2023-08-03T18:30:00.000Z",
  "pageHeading": "Concord Biotech Limited IPO (Concord Biotech IPO) Detail",
  "pageTitle": "Concord Biotech IPO Date, Price, GMP, Review, Details",
  "promoterHolding": {
    "promoters": "Sudhir Vaid and Ankur Vaid are the Company Promoters.",
    "holdings": {
      "share_holding_pre_issue": "44.08%",
      "share_holding_post_issue": "44.08%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Concord Biotech IPO DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/aug-2022/concord-biotech-limited_61961.html"
    },
    {
      "text": "Concord Biotech IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/aug-2023/concord-biotech-limited-prospectus_75465.html"
    },
    {
      "text": "Anchor Investors in Concord Biotech IPO",
      "url": "https://www.chittorgarh.net/reports/ipo_notes/concord-biotech-anchor-intimation-letter.pdf"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "9",
        "neutral": "1",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "7",
        "neutral": "2",
        "avoid": "3"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/concord-biotech-ipo/1472/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Link Intime India Private Ltd",
    "phone": "+91-22-4918 6270",
    "email": "concordbiotech.ipo@linkintime.co.in",
    "website": "https://linkintime.co.in/Initial_Offer/public-issues.html"
  },
  "reservation": {
    "summary": "Concord Biotech IPO offers 20925652 shares. 4183130 (19.99%) to QIB 3137348 (14.99%) to NII 7320479 (34.98%) to RII 10000 (0.05%) to employees 6274695 (29.99%) to Anchor investors. 366023 RIIs will receive minimum 20 shares and 3734 (sNII) and 7469 (bNII) will receive minimum 280 shares. (in case of oversubscription)",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "6274695 (29.99%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "4183130 (19.99%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "3137348 (14.99%)"
      },
      {
        "investor_category": "bNII > 10L",
        "shares_offered": "2091565 (10.00%)",
        "maximum_allottees": "7469"
      },
      {
        "investor_category": "sNII < 10L",
        "shares_offered": "1045783 (5.00%)",
        "maximum_allottees": "3734"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "7320479 (34.98%)",
        "maximum_allottees": "366023"
      },
      {
        "investor_category": "Employee Shares Offered",
        "shares_offered": "10000 (0.05%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "20925652 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T17:40:43.650Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Concord Biotech IPO is subscribed 24.87 times on August 8 2023 7:02:00 PM (Day 3). The public issue subscribed 3.78 times in the retail category 67.67 times in the QIB category and 16.99 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "67.67",
        "shares_offered": "4183130",
        "shares_bid_for": "283064540"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "16.99",
        "shares_offered": "3137348",
        "shares_bid_for": "53305680"
      },
      "bnii": {
        "category": "bNII (bids above 10L)",
        "subscription_times": "19.3",
        "shares_offered": "2091565",
        "shares_bid_for": "40368000"
      },
      "snii": {
        "category": "sNII (bids below 10L)",
        "subscription_times": "12.37",
        "shares_offered": "1045783",
        "shares_bid_for": "12937680"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "3.78",
        "shares_offered": "7320479",
        "shares_bid_for": "27682480"
      },
      "employee": {
        "category": "Employee",
        "subscription_times": "24.48",
        "shares_offered": "10000",
        "shares_bid_for": "244840"
      },
      "total": {
        "category": "Total",
        "subscription_times": "24.87",
        "shares_offered": "14650957",
        "shares_bid_for": "364297540"
      }
    },
    "total_applications": "1264369"
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on August 8 2023",
    "tentative_allotment": "Fri Aug 11 2023",
    "initiation_of_refunds": "Mon Aug 14 2023",
    "credit_of_shares_to_demat": "Thu Aug 17 2023"
  },
  "updatedAt": "2025-04-19T04:37:28.919Z",
  "updated_at": "2025-04-18T17:40:43.650Z",
  "year": 2023,
  "worst_listing_gains": "27.11%",
  "worst_listing_gains_numeric": 27.11
}